XML 35 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Restatement of Previously Issued Financial Statements (Tables)
12 Months Ended
Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement of Previously Issued Financial Statements

The effect of the restatements on the consolidated balance sheets for December 31, 2018 and 2017 are as follows:

 

    For the Year Ended
December 31, 2018
    For the Year Ended
December 31, 2017
 
    As Reported     Restatement Adjustment     As Restated     As Reported     Restatement Adjustment     As Restated  
Statement of Operations:                                                
Revenue   $ 18,245,212     $ -     $ 18,245,212     $ 15,595,659     $ -     $ 15,595,659  
Cost of revenue     7,077,344       -       7,077,344       5,960,223       -       5,960,223  
Selling, general and administrative expenses     7,107,432       -       7,107,432       5,734,315       -       5,734,315  
Depreciation and amortization expense     3,760,231       -       3,760,231       3,676,598       -       3,676,598  
Total operating costs and expenses     17,945,007       -       17,945,007       15,371,136       -       15,371,136  
Operating income (loss)     300,205       -       300,205       224,523       -       224,523  
Other income (expense)                                                
Interest income     432,753       (377,746 )     55,007       346,926       (338,204 )     8,722  
Interest expense     (773,680 )     -       (773,680 )     (905,990 )     -       (905,990 )
Other income     -       -       -       43,669               43,669  
Gain (loss) on disposition of assets     (14,013 )     -       (14,013 )     12,167               12,167  
Provision for related party note receivable     -       -       -       -       (6,979,043 )     (6,979,043 )
Recovery on related party note receivable     -       377,746       377,746       -       717,709       717,709  
Total other expense     (354,940 )     -       (354,940 )     (503,228 )     (6,599,538 )     (7,102,766 )
Net income (loss) before income taxes     (54,735 )     -       (54,735 )     (278,705 )     (6,599,538 )     (6,878,243 )
Income tax expense     (3,640 )     -       (3,640 )     -       -       -  
Net income (loss)     (58,375 )     -       (58,375 )     (278,705 )     (6,599,538 )     (6,878,243 )
Earnings (loss) per common share - basic   $ (0.00 )   $ -     $ (0.00 )   $ (0.01 )   $ (0.27 )   $ (0.28 )
Earnings (loss) per common share - diluted   $ (0.00 )   $ -     $ (0.00 )   $ (0.01 )   $ (0.27 )   $ (0.28 )
Weighted average common shares outstanding - basic     24,608,967       24,608,967       24,608,967       24,268,409       24,268,409       24,268,409  
Weighted average common shares outstanding - diluted     24,608,967       24,608,967       24,608,967       24,268,409       24,268,409       24,268,409  
Balance Sheet:                                                
Current assets   $ 7,675,186     $ -     $ 7,675,186     $ 6,350,564     $ -     $ 6,350,564  
Total assets     27,006,405       (7,367,212 )     19,639,193       28,675,856       (7,367,212 )     21,308,644  
Current liabilities     5,931,980       -       5,931,980       7,666,905       -       7,666,905  
Total liabilities     12,228,974       -       12,228,974       14,373,280       -       14,373,280  
Total shareholders’ equity     14,777,431       (7,367,212 )     7,410,219       14,302,576       (7,367,212 )     6,935,364  
Total liabilities and shareholders’ equity     27,006,405       (7,367,212 )     19,639,193       28,675,856       (7,367,212 )     21,308,644